Literature DB >> 26438676

DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment.

Paul W Blair1, Douglas Herrin1, Nawaf Abaalkhail1, Wesley Fiser1.   

Abstract

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is characterised by fever, rash, eosinophilia and organ damage that develops 2-6 weeks after the initiation of a medication. We report a case of DRESS syndrome in a 79-year-old man that developed after the introduction of rifabutin, ethambutol and clarithromycin used to treat Mycobacterium avium complex (MAC) vertebral osteomyelitis. This case highlights treatment and management challenges in a patient with known MAC vertebral osteomyelitis requiring prolonged steroids. Steroids are the mainstays of treatment for moderate to severe cases of DRESS syndrome. Initiation of steroids for the treatment of DRESS syndrome among patients with concomitant infections requires multidisciplinary collaboration for optimal management. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26438676      PMCID: PMC4600809          DOI: 10.1136/bcr-2015-210907

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome.

Authors:  Yoko Kano; Tadashi Ishida; Kazuhisa Hirahara; Tetsuo Shiohara
Journal:  Med Clin North Am       Date:  2010-07       Impact factor: 5.456

Review 2.  Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.

Authors:  S A Walsh; D Creamer
Journal:  Clin Exp Dermatol       Date:  2011-01       Impact factor: 3.470

Review 3.  The DRESS syndrome: a literature review.

Authors:  Patrice Cacoub; Philippe Musette; Vincent Descamps; Olivier Meyer; Chris Speirs; Laetitia Finzi; Jean Claude Roujeau
Journal:  Am J Med       Date:  2011-05-17       Impact factor: 4.965

Review 4.  DRESS syndrome: Part II. Management and therapeutics.

Authors:  Zain Husain; Bobby Y Reddy; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2013-05       Impact factor: 11.527

Review 5.  DRESS syndrome: Part I. Clinical perspectives.

Authors:  Zain Husain; Bobby Y Reddy; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2013-05       Impact factor: 11.527

6.  Difficult clinical management of anti-tuberculosis DRESS syndrome.

Authors:  D Palmero; J Castagnino; R M Musella; C Mosca; P González Montaner; G C de Casado
Journal:  Int J Tuberc Lung Dis       Date:  2012-10-30       Impact factor: 2.373

7.  Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs.

Authors:  Joo Ho Lee; Hye-Kyung Park; Jeong Heo; Tae Oh Kim; Gwang Ha Kim; Dae Hwan Kang; Geun Am Song; Mong Cho; Dae Sung Kim; Hwal Woong Kim; Chang Hun Lee
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

  7 in total
  1 in total

Review 1.  Macrolide Allergic Reactions.

Authors:  Kristy M Shaeer; Elias B Chahine; Sheeba Varghese Gupta; Jonathan C Cho
Journal:  Pharmacy (Basel)       Date:  2019-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.